ABSTRACT
Hereditary spherocytosis (HS) is a congenital disorder of the red blood cell membrane and is characterized by hemolytic anemia, variable jaundice, and splenomegaly. In neonates, the diagnosis of HS can be difficult in the absence of family history. Herein, we describe clinical and molecular genetic findings in a Korean neonate with HS. A one-month-old girl presented with severe anemia and jaundice. Spherocytes were frequently observed on peripheral blood smear, but the erythrocyte osmotic fragility test result was normal. Targeted next-generation sequencing (NGS) revealed the patient was heterozygous for a novel frameshift mutation, c.191_194del (p.Leu64Argfs*7), in exon 3 of ANK1 gene. Family study was performed by direct sequencing, and neither of her parents carried this mutation. The patient also harbored the UGT1A1*6 allele. To the best of our knowledge, this ANK1 mutation identified by targeted NGS has not been reported previously.
Subject(s)
Ankyrins/genetics , Spherocytosis, Hereditary/genetics , Alleles , Ankyrins/metabolism , Female , Heterozygote , High-Throughput Nucleotide Sequencing/methods , Humans , Infant, Newborn , Mutation , Republic of Korea , Spherocytes/cytology , Spherocytosis, Hereditary/diagnosis , Spherocytosis, Hereditary/metabolismABSTRACT
Permanent availability of red blood cells (RBCs) for transfusion depends on refrigerated storage, during which morphologically altered RBCs accumulate. Among these, a subpopulation of small RBCs, comprising type III echinocytes, spheroechinocytes, and spherocytes and defined as storage-induced microerythrocytes (SMEs), could be rapidly cleared from circulation posttransfusion. We quantified the proportion of SMEs in RBC concentrates from healthy human volunteers and assessed correlation with transfusion recovery, investigated the fate of SMEs upon perfusion through human spleen ex vivo, and explored where and how SMEs are cleared in a mouse model of blood storage and transfusion. In healthy human volunteers, high proportion of SMEs in long-stored RBC concentrates correlated with poor transfusion recovery. When perfused through human spleen, 15% and 61% of long-stored RBCs and SMEs were cleared in 70 minutes, respectively. High initial proportion of SMEs also correlated with high retention of RBCs by perfused human spleen. In the mouse model, SMEs accumulated during storage. Transfusion of long-stored RBCs resulted in reduced posttransfusion recovery, mostly due to SME clearance. After transfusion in mice, long-stored RBCs accumulated predominantly in spleen and were ingested mainly by splenic and hepatic macrophages. In macrophage-depleted mice, splenic accumulation and SME clearance were delayed, and transfusion recovery was improved. In healthy hosts, SMEs were cleared predominantly by macrophages in spleen and liver. When this well-demarcated subpopulation of altered RBCs was abundant in RBC concentrates, transfusion recovery was diminished. SME quantification has the potential to improve blood product quality assessment. This trial was registered at www.clinicaltrials.gov as #NCT02889133.
Subject(s)
Blood Preservation , Erythrocytes , Animals , Erythrocyte Transfusion , Kinetics , Mice , SpherocytesABSTRACT
BACKGROUND: The Advanced RBC Application of the CellaVision DM9600 system (CellaVision AB, Lund, Sweden) automatically characterizes and classifies red blood cells (RBCs) into 21 morphological categories based on their size, color, shape, and inclusions. We evaluated the diagnostic performance of the CellaVision Advanced RBC Application with respect to the classification and grading of RBC morphological abnormalities in accordance with the 2015 International Council for Standardization in Haematology (ICSH) guidelines. METHODS: A total of 223 samples, including 123 with RBC morphological abnormalities and 100 from healthy controls, were included. Seven RBC morphological abnormalities and their grading obtained with CellaVision DM9600 pre- and post-classification were compared with the results obtained using manual microscopic examination. The grading cut-off percentages were determined in accordance with the 2015 ICSH guidelines. The sensitivity and specificity of the CellaVision DM9600 system were evaluated using the manual microscopic examination results as a true positive. RESULTS: In pre-classification, >90% sensitivity was observed for target cells, tear drop cells, and schistocytes, while >90% specificity was observed for acanthocytes, spherocytes, target cells, and tear drop cells. In post-classification, the detection sensitivity and specificity of most RBC morphological abnormalities increased, except for schistocytes (sensitivity) and acanthocytes (specificity). The grade agreement rates ranged from 35.9% (echinocytes) to 89.7% (spherocytes) in pre-classification and from 46.2% (echinocytes) to 90.1% (spherocytes) in post-classification. The agreement rate of samples with within-one grade difference exceeded 90% in most categories, except for schistocytes and echinocytes. CONCLUSIONS: The Advanced RBC Application of CellaVision DM9600 is a valuable screening tool for detecting RBC morphological abnormalities.
Subject(s)
Erythrocytes, Abnormal/cytology , Microscopy/methods , Acanthocytes/classification , Acanthocytes/cytology , Area Under Curve , Case-Control Studies , Erythrocytes, Abnormal/classification , Humans , Microscopy/instrumentation , ROC Curve , Retrospective Studies , Spherocytes/classification , Spherocytes/cytologyABSTRACT
This case report describes a massive honey bee envenomation in a 14-month-old male Belgian Malinois dog from St. Kitts, West Indies. Acute and delayed onsets of hemolytic anemia, echinocytosis, spherocytosis, thrombocytopenia, hemoglobinemia, and hemoglobinuria developed following envenomation. The dog recovered after treatment with glucocorticoids and supportive therapy. Spherocytosis, hemolysis, and thrombocytopenia in patients with massive bee envenomation are likely due to the direct toxic effects of the primary components of bee venom, melittin and phospholipase A2 (PLA2 ). Mellitin causes hemolysis by forming large pores in erythrocytes resulting in leakage of hemoglobin and also causes spectrin stiffening and resultant echinocyte and spherocyte formation. Melittin also stimulates PLA2 , a hydrolase that causes echinocytosis and spherocytosis, in vivo and in vitro, and mitochondrial breakdown in platelets. However, delayed manifestations could be attributed to immune-mediated mechanisms from the generation of antibodies against damaged erythrocytes and platelet membrane proteins.
Subject(s)
Anemia, Hemolytic/veterinary , Bee Venoms/poisoning , Bees , Dog Diseases/etiology , Insect Bites and Stings/veterinary , Spherocytes , Thrombocytopenia/veterinary , Anemia, Hemolytic/etiology , Animals , Blood Cell Count/veterinary , Dogs , Insect Bites and Stings/complications , Male , Thrombocytopenia/etiologyABSTRACT
BACKGROUND: Current diagnostic tests for hereditary spherocytosis (HS) focus on the detection of hemolysis or indirectly assessing defects of membrane protein, whereas direct methods to detect protein defects are complicated and difficult to implement. In the present study, we investigated the patterns of genetic variation associated with HS among patients clinically diagnosed with HS. METHODS: Multi-gene targeted sequencing of 43 genes (17 RBC membrane protein-encoding genes, 20 RBC enzyme-encoding genes, and six additional genes for the differential diagnosis) was performed using the Illumina HiSeq platform. RESULTS: Among 59 patients with HS, 50 (84.7%) had one or more significant variants in a RBC membrane protein-encoding genes. A total of 54 significant variants including 46 novel mutations were detected in six RBC membrane protein-encoding genes, with the highest number of variants found in SPTB (n = 28), and followed by ANK1 (n = 19), SLC4A1 (n = 3), SPTA1 (n = 2), EPB41 (n = 1), and EPB42 (n = 1). Concurrent mutations of genes encoding RBC enzymes (ALDOB, GAPDH, and GSR) were detected in three patients. UGT1A1 mutations were present in 24 patients (40.7%). Positive rate of osmotic fragility test was 86.8% among patients harboring HS-related gene mutations. CONCLUSIONS: This constitutes the first large-scaled genetic study of Korean patients with HS. We demonstrated that multi-gene target sequencing is sensitive and feasible that can be used as a powerful tool for diagnosing HS. Considering the discrepancies of clinical and molecular diagnoses of HS, our findings suggest that molecular genetic analysis is required for accurate diagnosis of HS.
Subject(s)
Osmotic Fragility/physiology , Spherocytes/metabolism , Spherocytosis, Hereditary/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Anion Exchange Protein 1, Erythrocyte/genetics , Anion Exchange Protein 1, Erythrocyte/metabolism , Ankyrins/genetics , Ankyrins/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Child , Child, Preschool , Cytoskeletal Proteins/genetics , Cytoskeletal Proteins/metabolism , Female , Glucuronosyltransferase/genetics , Glucuronosyltransferase/metabolism , Humans , Infant , Male , Membrane Proteins/genetics , Membrane Proteins/metabolism , Microfilament Proteins/genetics , Microfilament Proteins/metabolism , Middle Aged , Mutation/genetics , Osmotic Fragility/genetics , Pathology, Molecular , Republic of Korea , Spectrin/genetics , Spectrin/metabolism , Spherocytosis, Hereditary/genetics , Young AdultABSTRACT
Distortions of the normal bi-concave disc shape for red blood cells (RBCs) appear in a number of pathologies resulting from defects in cell membrane skeletal architecture, erythrocyte ageing, and mechanical damage. We present here the potential of acoustic cytometry for developing new approaches to light-scattering based evaluation of red blood cell disorders and of the effects of storage and ageing on changes or damage to RBCs membranes. These approaches could be used to immediately evaluate the quality of erythrocytes prior to blood donation and following transfusion. They could also be applied to studying RBC health in diseases and other pathologies, such as artificial heart valve hemolysis, thermal damage or osmotic fragility. Abnormal distributions of erythrocytes can typically be detected after just 30 to 45 seconds of acquisition time using 1-2 µL starting blood volumes.
Subject(s)
Erythrocytes , Flow Cytometry/methods , Sound , Annexin A5 , Blood Preservation/methods , Erythrocyte Aging , Erythrocyte Deformability , Erythrocyte Indices , Erythrocyte Membrane/ultrastructure , Erythrocyte Transfusion , Erythrocytes/ultrastructure , Flow Cytometry/instrumentation , Fluorescent Dyes , Hemolysis , Humans , Hydrodynamics , Light , Membrane Lipids/blood , Phosphatidylserines/blood , Scattering, Radiation , Spherocytes/ultrastructure , Spherocytosis, Hereditary/bloodSubject(s)
Anion Exchange Protein 1, Erythrocyte/metabolism , Eosine Yellowish-(YS)/analogs & derivatives , Spherocytes/metabolism , Spherocytosis, Hereditary/metabolism , Adolescent , Adult , Age Factors , Child , Child, Preschool , Eosine Yellowish-(YS)/chemistry , Eosine Yellowish-(YS)/metabolism , Humans , Infant , Infant, Newborn , Middle Aged , Protein Binding , Reference Values , Young AdultABSTRACT
INTRODUCTION: Hereditary spherocytosis (HS) is the most common congenital hemolytic anemia, characterized by anemia, jaundice, and splenomegaly. The diagnosis of HS relies on symptoms of hemolysis, a family history of HS, and a positive laboratory test which is usually the osmotic fragility test (OFT). We conducted a study to assess the utility of mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV), mean sphered cell volume (MSCV), and mean reticulocyte volume (MRV) in the diagnosis of HS and if these are helpful in distinguishing cases of HS from immune hemolytic anemia. METHODS: A total of 102 patients suspected to have HS were enrolled. In addition 10 cases of immune hemolytic anemia (IHA) were included in the study and performance of the above screening tests was evaluated. The diagnosis of HS was based on incubated OFT, eosin 5'-maleimide (EMA) dye binding test, and flowcytometric OFT. RESULTS: A total of 29 patients were diagnosed as having HS. The sensitivity and specificity for diagnosis HS by MCHC > 35â g/dL was 44.82%, and ΔMCV-MSCV > 10â fL has a sensitivity and specificity of 82.75% and 95.9% for diagnosis of HS. Using an algorithm of ΔMCV-MSCV > 10â fL and ΔMRV-MSCV < 25, for the differentiation of HS from IHA had sensitivity of 68.9% and specificity of 98.8%.
Subject(s)
Reticulocytes , Spherocytes , Spherocytosis, Hereditary/blood , Spherocytosis, Hereditary/diagnosis , Adolescent , Adult , Child , Child, Preschool , Erythrocyte Indices , Female , Flow Cytometry , Hemolysis , Humans , Infant , Infant, Newborn , Male , Middle Aged , Sensitivity and Specificity , Young AdultSubject(s)
Anemia, Hemolytic/etiology , Bacteremia/microbiology , Clostridium Infections/complications , Clostridium perfringens/isolation & purification , Erythrocyte Membrane/ultrastructure , Shock, Septic/etiology , Spherocytes/ultrastructure , Aged , Anemia, Hemolytic/blood , Bacteremia/blood , Clostridium Infections/blood , Clostridium Infections/diagnosis , Clostridium Infections/microbiology , Fatal Outcome , Humans , Liver Abscess/diagnostic imaging , Liver Abscess/etiology , Liver Abscess/microbiology , Male , Multiple Organ Failure/etiologyABSTRACT
Patients with combined hereditary spherocytosis (HS) and uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) deficiency have been reported sporadically. A discrepancy between the level of elevated serum bilirubin concentration and the degree of anemia may suggest the possibility of a coexistence of these conditions. In the present case report, a 20yearold female presented with congenital jaundice and anemia, but did not present with the discrepancy between hyperbilirubinemia and anemia in the patient's childhood, and was not previously diagnosed with either HS or UGT1A1 deficiency. During a followup of >10 years, the patient's hyperbilirubinemia accumulated progressively, whereas the patient's anemia became relatively mild. Upon further genetic analysis, it was determined that the patient had HS combined with UGT1A1 partial deficiency. Next generation sequencing combined with direct sequencing was used to identify a novel heterozygous mutation (c.G828T; p.Y276X) in the spectrin ß gene, which is causative for HS. Sequence analysis of the patients' UGT1A1 gene revealed a compound heterozygote with c.G211A (p.G71R) and T3279G mutations, which reduced UGT1A1 activity to 3060% of the normal level. Genetic analysis was crucial for determining the diagnosis and pathogenesis of this unusual case.
Subject(s)
Glucuronosyltransferase/genetics , Spherocytosis, Hereditary/diagnosis , Spherocytosis, Hereditary/genetics , Biomarkers , DNA Mutational Analysis , Female , Genetic Association Studies , Genetic Testing , Genotype , Glucuronosyltransferase/deficiency , Humans , Mutation , Phenotype , Spectrin/genetics , Spherocytes/pathology , Spherocytosis, Hereditary/blood , Young AdultSubject(s)
Burns/blood , Blood Platelets/pathology , Burns/diagnostic imaging , Child, Preschool , Diagnostic Imaging , Elliptocytosis, Hereditary/blood , Elliptocytosis, Hereditary/diagnosis , Erythrocytes/pathology , Humans , Leukocytosis/diagnostic imaging , Male , Spherocytes/pathology , Thrombocytosis/diagnostic imagingSubject(s)
Anemia, Hemolytic, Autoimmune/blood , Autoantibodies/blood , Coombs Test , Immunoglobulin A/blood , Anemia, Hemolytic, Autoimmune/etiology , Anemia, Hemolytic, Autoimmune/immunology , False Negative Reactions , Female , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/immunology , Humans , Middle Aged , Spherocytes/immunologyABSTRACT
Hereditary spherocytosis (HS) is a disease affecting the red blood cells membrane and belongs to the congenital hemolytic anemias. The clinical spectrum ranges from asymptomatic patients to severe forms requiring transfusions in early childhood. The diagnosis can be based on the physical examination, complete red blood cell count, reticulocytes count, medical history and specific tests, preferentially the EMA test (eosin-5-maleimide binding) test and AGLT (Acidified Glycerol Lysis Time). Splenectomy is considered the standard surgical treatment in moderate and severe forms of hereditary spherocytosis. Total splenectomy exposes the patient to a life - long risk of potentially lethal infections and thus, its usage was reconsidered. Because of this reason, a feasible alternative is the partial splenectomy. The use of partial splenectomy aims to retain splenic immunologic function, while at the same time to decrease the rate of hemolysis. The long - term outcomes of patients with total or subtotal splenectomy for congenital hemolytic anemia, still remain unclear, but the majority of the studies showed a qualitative resolution of anemia and reduction of transfusion rate. Despite the well known advantages of conservative surgery, the optimal choice of treatment and outcomes should be confirmed with the patient.
Subject(s)
Erythrocyte Count , Reticulocytes , Spherocytosis, Hereditary/diagnosis , Spherocytosis, Hereditary/surgery , Splenectomy , Erythrocyte Count/methods , Erythrocyte Membrane , Evidence-Based Medicine , Hematologic Tests , Hemolysis , Humans , Reticulocytes/cytology , Spherocytes/metabolism , Splenectomy/methods , Treatment OutcomeABSTRACT
BACKGROUND: Storage lesion may explain the rapid clearance of up to 25% of transfused red blood cells (RBCs) in recipients. Several alterations affect stored RBC but a quantitative, whole cell-based predictor of transfusion yield is lacking. Because RBCs with reduced surface area are retained by the spleen, we quantified changes in RBC dimensions during storage. STUDY DESIGN AND METHODS: Using imaging flow cytometry we observed the dimension and morphology of RBCs upon storage, along with that of conventional biochemical and mechanical markers of storage lesion. We then validated these findings using differential interference contrast (DIC) microscopy and quantified the accumulation of microparticles (MPs). RESULTS: Mean projected surface area of the whole RBC population decreased from 72.4 to 68.4 µm2 , a change resulting from the appearance of a well-demarcated subpopulation of RBCs with reduced mean projected surface (58 µm2 , 15.2%-19.9% reduction). These "small RBCs" accounted for 4.9 and 23.6% of all RBCs on Days 3 and 42 of storage, respectively. DIC microscopy confirmed that small RBCs had shifted upon storage from discocytes to echinocytes III, spheroechinocytes, and spherocytes. Glycophorin A-positive MPs and small RBCs appeared after similar kinetics. CONCLUSION: The reduction in surface area of small RBCs is expected to induce their retention by the spleen. We propose that small RBCs generated by MP-induced membrane loss are preferentially cleared from the circulation shortly after transfusion of long-stored blood. Their operator-independent quantification using imaging flow cytometry may provide a marker of storage lesion potentially predictive of transfusion yield.
Subject(s)
Blood Preservation , Cell-Derived Microparticles , Flow Cytometry/methods , Spherocytes/cytology , Biomarkers/blood , Female , Humans , Kinetics , Male , Spherocytes/metabolism , Time FactorsABSTRACT
In this paper, an attempt has been made to study sedimentation of a red blood cell (RBC) in a plasma-filled tube numerically. Such behaviors are studied for a healthy and a defective cell which might be created due to human diseases, such as diabetes, sickle-cell anemia, and hereditary spherocytosis. Flow-induced deformation of RBC is obtained using finite-element method (FEM), while flow and fluid-membrane interaction are handled using lattice Boltzmann (LB) and immersed boundary methods (IBMs), respectively. The effects of RBC properties as well as its geometry and orientation on its sedimentation rate are investigated and discussed. The results show that decreasing frontal area of an RBC and/or increasing tube diameter results in a faster settling. Comparison of healthy and diabetic cells reveals that less cell deformability leads to slower settling. The simulation results show that the sicklelike and spherelike RBCs have lower settling velocity as compared with a biconcave discoid cell.
Subject(s)
Erythrocytes/cytology , Erythrocytes/pathology , Finite Element Analysis , Mechanical Phenomena , Models, Biological , Plasma/cytology , Anemia, Sickle Cell/blood , Biomechanical Phenomena , Blood Sedimentation , Diabetes Mellitus/blood , Erythrocyte Deformability , Erythrocyte Membrane/metabolism , Erythrocytes/physiology , Humans , Spherocytes/cytology , Spherocytes/pathologyABSTRACT
Exact diagnosis of hereditary spherocytosis (HS) is widely considered unreliable around birth. However, early postnatal diagnosis at the beginning of congenital hemolysis may be essential for managing neonatal anemia and hemolytic icterus, identifying those at high risk for severe hyperbilirubinemia, irreversible kernicterus, or sudden need for red cell transfusion. We analyzed 37 blood samples from neonates or infants up to six weeks of life that had been collected in-house or shipped to our laboratory due to suspected red cell membrane disorder. By combining assessment of red cell morphology, acidified glycerol lysis test (AGLT), and eosin-5'-maleimide (EMA) binding assay, we were able to clearly exclude HS in 22 and confirm HS in 10 patients, of which one had undergone red cell transfusion prior to blood sampling. Assessment of red cell morphology and normal test results allowed diagnosis of infantile pyknocytosis or Heinz body anemia in three neonates. Re-evaluation of five patients with inconsistent results of AGLT and EMA binding led to confirmation of HS in two cases. Automated analysis of hematologic parameters revealed elevated proportion of hyperdense cells to be a highly significant indicator for HS in neonatal infants. We showed that assessment of red cell morphology in combination with AGLT and EMA binding assay is a reliable basis for confirming or rejecting suspected diagnosis of HS even in neonates. Our data underline the necessity for blood sampling and laboratory exploration in suspected red cell membrane or enzyme defects at the earliest occasion.
Subject(s)
Eosine Yellowish-(YS)/analogs & derivatives , Erythrocyte Membrane , Glycerol/chemistry , Spherocytes , Spherocytosis, Hereditary/diagnosis , Eosine Yellowish-(YS)/chemistry , Erythrocyte Membrane/chemistry , Erythrocyte Membrane/pathology , Female , Humans , Infant , Infant, Newborn , Male , Spherocytes/chemistry , Spherocytes/metabolismABSTRACT
CONTEXT: Mean sphered cell volume (MSCV) and mean reticulocyte volume (MRV) are additional reticulocyte parameters generated while processing the blood samples on Beckman coulter LH 755 in the reticulocyte mode using the volume, conductivity and scatter technology. It has been observed that the difference between mean corpuscular volume (MCV) and MSCV is higher in the cases of hereditary spherocytosis (HS) and this difference is increasingly being utilized as a screening tool for spherocytes. In addition now there have been new observations that reticulocyte volume in cases of HS is less as compared to normal reticulocyte. AIMS: Our aim was to test the usefulness of reticulocyte parameters like MSCV and MRV in distinguishing cases of HS and autoimmune hemolytic anemia (AIHA). MATERIALS AND METHODS: This is a retrospective and partly prospective study where peripheral blood ethylenediaminetetraacetic acid samples from cases of HS (n = 57) and AIHA (n = 29) were processed on LH 755 in both the differential and the reticulocyte mode. The data generated were analyzed and compared with data from normal healthy donors (n = 46). RESULTS: Using an algorithm of MCV - MSCV >10 and MRV - MSCV <25, a sensitivity of 84.2% and specificity of 94.7% was observed in cases of HS. CONCLUSIONS: With the reticulocyte analysis, we may now have a simple and cheap additional tool for screening of HS.